The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
The vivo Y21 launched in 2021, and now the brand is working on the Y21 5G. Weird, we know, but apparently vivo couldn't help but reuse this name, despite there being an infinite number of other ...
Santen Pharmaceutical Co. Ltd. (4536.TO) Japan Nine Months Ended December 31 GROUP 2025 2024 Revenue Y210.76 bln Y222.77 bln Operating Profit Y28.22 bln Y35.20 bln Net Profit Y21.82 bln Y27.47 bln Per ...
When dabbling in any of the titles on our best FPS games list, the goal is to feel locked-in and immersed. You want to feel the bright-white flash and piercing ring ...
The partnership is similar to one between Dexcom and Oura. The partnership is similar to one between Dexcom and Oura. is a senior reporter and author of the Optimizer newsletter. She has more than 13 ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company operating at the intersection of technology, wellness, and ...
Though Counter’s mission to transform the clean beauty world and empower women hasn’t changed, its products, their packaging, and so much more has. “Changing the name was an opportunity for us for a ...
Although the FDA approved OTC naloxone to facilitate access, sales peaked in the first month it was available before quickly decreasing. The number of OTC units sold per million residents was much ...
Share on Pinterest A new study found that OTC birth control has significantly expanded access to a safe and reliable birth control method. Carol Yepes/Getty Images In 2023, the FDA approved Opill, the ...
OTC Markets Group Inc. (OTCM) shares rallied 6.1% in the last trading session to close at $60.5. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results